Soleus Capital Management’s Denali Therapeutics DNLI Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	$2.55M	Buy	182,110 +47,110	+35%	+$659K	0.17%	71
2025 Q1	$1.84M	Buy	+135,000	New	+$1.84M	0.13%	63
2024 Q2	–	Sell	-47,000	Closed	-$964K	–	98
2024 Q1	$964K	Sell	47,000 -83,000	-64%	-$1.7M	0.07%	82
2023 Q4	$2.79M	Buy	+130,000	New	+$2.79M	0.31%	50